{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:54:37Z","timestamp":1769151277350,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejps.2021.105909","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T08:44:00Z","timestamp":1623401040000},"page":"105909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia"],"prefix":"10.1016","volume":"164","author":[{"given":"Praveen K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hetal P.","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105909_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0223-5234(96)80448-X","article-title":"Synthesis and antiamnesic activity of a series of N-acylprolyl-containing dipeptides","volume":"31","author":"Gudasheva","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105909_bib0002","first-page":"66","article-title":"The original novel nootropic and neuroprotective agent noopept","volume":"65","author":"Ostrovskaia","year":"2002","journal-title":"Eksp. Klin. Farmakol."},{"key":"10.1016\/j.ejps.2021.105909_bib0003","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11055-009-9128-4","article-title":"Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin","volume":"39","author":"Neznamov","year":"2009","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.ejps.2021.105909_bib0004","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10517-008-0297-x","article-title":"Noopept stimulates the expression of NGF and BDNF in rat hippocampus","volume":"146","author":"Ostrovskaya","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ejps.2021.105909_bib0005","first-page":"40","article-title":"Interspecies differences of noopept pharmacokinetics","volume":"67","author":"Bo\u012dko","year":"2004","journal-title":"Eksp. Klin. Farmakol."},{"key":"10.1016\/j.ejps.2021.105909_bib0006","series-title":"Nanocosmetics and Nanomedicines","first-page":"139","article-title":"Elastic liposomes","author":"Santana","year":"2011"},{"key":"10.1016\/j.ejps.2021.105909_bib0007","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0378-5173(02)00266-1","article-title":"Elastic liposomes for skin delivery of dipotassium glycyrrhizinate","volume":"241","author":"Trotta","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105909_bib0008","first-page":"1475","article-title":"The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic","volume":"11","author":"Singh","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2021.105909_bib0009","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2174\/1567201813666160120151816","article-title":"Ethosomal hydrogel of raloxifene HCl: statistical optimization & ex vivo permeability evaluation across microporated Pig ear skin","volume":"13","author":"Thakkar","year":"2016","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.ejps.2021.105909_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2017.04.001","article-title":"Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: a patient friendly approach to manage arthritis","volume":"104","author":"Amodwala","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105909_bib0011","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2021.105909_bib0012","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1002\/jps.24563","article-title":"Design of a dissolving microneedle platform for transdermal delivery of a fixed-dose combination of cardiovascular drugs","volume":"104","author":"Quinn","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105909_bib0013","series-title":"Guidance For industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials For Therapeutics in Adult Healthy Volunteers","first-page":"7","year":"2005"},{"key":"10.1016\/j.ejps.2021.105909_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2560001","article-title":"The mechanism of vesicle formation","volume":"256","author":"Lasic","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2021.105909_bib0015","series-title":"Liposome For Incorporating Large Amounts of Hydrophobic Substances","author":"Kan","year":"2002"},{"key":"10.1016\/j.ejps.2021.105909_bib0016","first-page":"18","article-title":"Microneedles: an innovative approach to transdermal delivery\u2014A review","volume":"6","author":"Akhtar","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci"},{"key":"10.1016\/j.ejps.2021.105909_bib0017","first-page":"67","article-title":"Critical issues related to transfersomes - novel vesicular system, Acta scientiarum polonorum","volume":"11","author":"Vinod","year":"2012","journal-title":"Technol. Aliment."},{"key":"10.1016\/j.ejps.2021.105909_bib0019","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-3659(03)00326-2","article-title":"Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid","volume":"92","author":"Essa","year":"2003","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2021.105909_bib0020","first-page":"97","article-title":"Kinetics and mechanisms of drug release from swellable and non swellable matrices: a review","volume":"4","author":"Chime","year":"2013","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"10.1016\/j.ejps.2021.105909_bib0021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/109158189801700408","article-title":"Final report on the safety assessment of polyvinylpyrrolidone (PVP)","volume":"17","author":"Nair","year":"1998","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ejps.2021.105909_bib0022","series-title":"Dissolving Microneedles: Safety Considerations and Future Perspectives","author":"Quinn","year":"2016"},{"key":"10.1016\/j.ejps.2021.105909_bib0023","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s11095-009-9967-2","article-title":"Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro","volume":"26","author":"Donnelly","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2021.105909_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118778","article-title":"A practical guide to the development of microneedle systems\u2013In clinical trials or on the market","volume":"573","author":"Lee","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105909_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13346-014-0211-1","article-title":"Considerations in the sterile manufacture of polymeric microneedle arrays","volume":"5","author":"McCrudden","year":"2015","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721002104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721002104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:54:13Z","timestamp":1744296853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"alternative-id":["S0928098721002104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105909","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105909"}}